Research Finds “Significant Decrease” In Post-Acute Sequelae Of COVID-19 Risk Among Patients With Rheumatic Diseases Since Pandemic Started

Healio (4/2, Cooper) reports, “Since the beginning of the COVID-19 pandemic, there has been a ‘significant decrease’ in the risk for post-acute sequelae of COVID-19 [PASC] among patients with rheumatic diseases, according to data.” Researchers found that “the risk for PASC among patients with” systemic autoimmune rheumatic diseases “was highest from March 2020 to June 2021, before decreasing through the delta...and omicron waves.” The findings were published in The Journal of Rheumatology.